Medication info

Unicollin Syrup (Choline Alfoscerate)

Prescription medicationSyrupOral
Ingredient · strength
Choline Alfoscerate›400mg / 1 packet
Manufacturer / importer
Korea Union Pharmaceutical Co., Ltd.
Appearance
A colorless or light yellow syrup with aromatic sweetness packed in aluminum foil pouches.
Packaging
30 pouches per pack [(8mL per pouch × 30)]
Approval status
Active

MFDS item code 201905732 · Notified 2019.08.14

Summary

Main use
Improvement of cerebrovascular deficits and degenerative organic brain symptoms (such as memory impairment and confusion)
Who takes it
Adults
Adult dose
Administer 400 mg (1 sachet) of choline alfoscerate orally per dose 2~3 times daily. Adjust the dose as appropriate according to symptoms.

Ingredients

Manufacturer
Korea Union Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of cerebrovascular deficits and degenerative organic brain symptoms (such as memory impairment and confusion)

  • Memory decline
  • confusion
  • spatial disorientation
  • decreased motivation
  • decreased spontaneity
  • decreased concentration
View approved original text

This medication is used for secondary symptoms caused by cerebrovascular deficits and degenerative or progressive organic brain syndrome. Major symptoms include memory decline, confusion, decreased motivation and spontaneity, spatial disorientation, and decreased concentration. This drug helps improve cognitive dysfunction and mental symptoms. Clinical trial results in Korea support this. Therefore, this medication supports the overall recovery of brain function and mental state.

How to take

Adult dose

Administer 400 mg (1 sachet) of choline alfoscerate orally per dose 2~3 times daily. Adjust the dose as appropriate according to symptoms.

Precautions

This medication should not be used by individuals who are allergic to this medication or its components. Also, women who are pregnant or may become pregnant should not take this medication. Nausea may occur upon taking this medication, which may be due to the action of the neurotransmitter dopamine in the brain; if symptoms are severe, the dosage should be reduced. It may affect the gastrointestinal system, potentially leading to gastritis or stomach disorders, thus caution is advisable. It may cause drowsiness, insomnia, irritability, or anxiety, and rarely, seizures or excessive movement may occur. This medication should be stored out of reach of children, and transferring it to another container can lead to accidents or deterioration of the drug quality, so it must be stored in the original container.

Side effects

  • Nausea
  • gastritis
  • gastric disease
  • drowsiness
  • insomnia
  • hostility
  • irritability
  • convulsions
  • hyperactivity

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture. It is recommended to maintain the storage temperature between 1 and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

A colorless or light yellow syrup with aromatic sweetness packed in aluminum foil pouches.

Package unit

30 pouches per pack [(8mL per pouch × 30)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.